Eastern Capital LTD's Net Worth

$354 Million

Estimate Recalculated May 31, 2025 01:59AM EST

Who is Eastern Capital LTD

Eastern Capital LTD has an estimated net worth of $354 Million. This is based on reported shares across multiple companies, which include AASTROM BIOSCIENCES INC, PEREGRINE PHARMACEUTICALS INC, CYTOKINETICS INC, Cyclacel Pharmaceuticals, Inc., iBio, Inc., and TAPIMMUNE INC.

SEC CIK

Eastern Capital LTD's CIK is 0001408408

Past Insider Trading and Trends

2016 was Eastern Capital LTD's most active year for acquiring shares with 6 total transactions. Eastern Capital LTD's most active month to acquire stocks was the month of April. 2020 was Eastern Capital LTD's most active year for disposing of shares, totalling 9 transactions. Eastern Capital LTD's most active month to dispose stocks was the month of July. 2020 saw Eastern Capital LTD paying a total of $6,285,000.40 for 29,341,667 shares, this is the most they've acquired in one year. In 2020 Eastern Capital LTD cashed out on 29,592,160 shares for a total of $98,166,409.01, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AASTROM BIOSCIENCES INC

Investor
Updated Jul 11, 2014
Form 4
$4.80
$1.74M
Jul 11, 2014
787.49K
Options
Jul 09
Form 3
Aug 23, 2013
8.50M
Showing 2 results

PEREGRINE PHARMACEUTICALS INC

Investor
Updated Sep 29, 2017
Form 4
Sep 29, 2017
4.22M
Form 3
Nov 02, 2015
26.44M
Showing 2 results

Cyclacel Pharmaceuticals, Inc.

Investor
Updated May 05, 2020
Form 4
May 05, 2020
65.86K
Form 4
64.53%
850.00K
$2.00
$1.70M
Jul 21, 2017
2.17M
Purchase
Jul 19
Form 3
Mar 17, 2015
5.61M
Showing 3 results

iBio, Inc.

Investor
Updated Aug 11, 2020
Form 4
105.70%
4.43M
$1.74
-$74.16M
Aug 11, 2020
8.63M
Sell-Options
Aug 07 - Aug 11
Form 4
-11.42%
-4.27M
$4.27
-$18.22M
Aug 06, 2020
33.11M
Sale
Aug 04 - Aug 06
Form 4
35.16%
2.20M
$0.90
$1.98M
Jul 13, 2018
8.46M
Purchase
Jul 12
Form 4
36.93%
1.69M
$500.45
$7.30M
Jun 28, 2018
6.26M
Purchase
Jun 26
Form 4
35.56%
12.00M
$0.20
$2.40M
Dec 04, 2017
45.74M
Purchase
Nov 30
Form 4
23.86%
6.50M
$0.62
$4.04M
Apr 11, 2016
33.74M
Purchase
Apr 07
Form 4
14.74%
3.50M
$0.59
$3.12M
Jan 27, 2016
27.24M
Purchase
Jan 25
Form 4/A
$0.40
Oct 17, 2013
21.96M
Options
Oct 15
Form 4
62.44%
6.24M
Apr 30, 2013
16.24M
Purchase
Apr 26
Form 3
Jan 19, 2012
10.00M
Showing 10 results

Marker Therapeutics, Inc.

Investor
Updated Nov 13, 2020
Form 4
Nov 13, 2020
4.05M
Form 4
-100.00%
-416.67K
Jun 19, 2020
Disposition
Jun 16
Form 4
$1.20
$500.00K
Feb 20, 2020
4.05M
Options
Feb 18
Form 4
32.50%
1.30M
$2.40
$3.12M
May 16, 2018
5.30M
Purchase
May 14
Form 4
40.00%
8.00M
$0.50
Aug 12, 2016
28.00M
Options
Aug 10
Form 4
$0.20
$2.00M
Sep 11, 2015
20.00M
Options
Sep 09
Form 4
$0.50
$2.50M
Jun 18, 2015
10.00M
Options
Jun 16
Form 4
10.00M
Jun 01, 2015
5.00M
Acq/Dis
May 28
Form 3
Mar 17, 2015
5.00M
Showing 9 results

CYTOKINETICS INC

Investor
Updated Feb 27, 2014
Form 4
20.97%
500.00K
$8.00
$4.00M
Feb 27, 2014
2.88M
Purchase
Feb 25
Form 3
Jul 02, 2012
14.30M
Showing 2 results